Literature DB >> 26782633

Surgical management of vestibular schwannomas after failed radiation treatment.

Yoichi Nonaka1,2, Takanori Fukushima3,4, Kentaro Watanabe3, Allan H Friedman3, Calhoun D Cunningham5, Ali R Zomorodi3.   

Abstract

Increasing numbers of patients with vestibular schwannoma (VS) have been treated with focused-beam stereotactic radiation treatment (SRT) including Gamma knife, CyberKnife, X-knife, Novalis, or proton beam therapy. The purpose of this study was to document the incidence of tumor regrowth or symptoms that worsened or first developed following SRT and to discuss surgical strategies for patients who have failed SRT for VS. A consecutive series of 39 patients with SRT failed VS were surgically treated. Clinical symptoms, tumor regrowth at follow-up, intraoperative findings, and surgical outcome were evaluated. There were 15 males and 24 females with a mean age of 51.8 years. Thirty-six patients (92.3%) demonstrated steady tumor growth after SRT. Two (5.1%) patients with slight increase of the mass underwent surgical resection because of development of unbearable facial pain. Symptoms that worsened or newly developed following SRT in this series were deafness (41%), dizziness (35.9%), facial numbness (25.6%), tinnitus (20.5%), facial nerve palsy (7.7%), and facial pain (7.7%). Intraoperative findings demonstrated fibrous changes of the tumor mass, cyst formation, and brownish-yellow or purple discoloration of the tumor capsule. Severe adhesions between the tumor capsule and cranial nerves, vessels, and the brainstem were observed in 69.2%. Additionally, the facial nerve was more fragile and irritable in all cases. Gross total resection (GTR) was achieved in 33.3% of patients, near-total resection (NTR) in 35.9%, and subtotal resection (STR) in 30.8% of patients. New facial nerve palsy was seen in seven patients (19.4%) postoperatively. Our findings suggest that patients with VS who fail SRT with either tumor progression or worsening of clinical symptoms will have an increased rate of adhesions to the neurovascular structures and may have radiation-influenced neuromalacia. Salvage surgery of radiation-failed tumors is more difficult and will have a higher risk of postoperative complications. Radical total resection may not be feasible, and conservative modality of subtotal resection needs to be considered to avoid new neurologic deficits.

Entities:  

Keywords:  Acoustic neuroma; Radiosurgery; Salvage microsurgery; Stereotactic radiation therapy; Vestibular schwannoma

Mesh:

Year:  2016        PMID: 26782633     DOI: 10.1007/s10143-015-0690-7

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  53 in total

1.  New and modified reporting systems from the consensus meeting on systems for reporting results in vestibular schwannoma.

Authors:  Jin Kanzaki; Mirko Tos; Mario Sanna; David A Moffat; Edwin M Monsell; Karen I Berliner
Journal:  Otol Neurotol       Date:  2003-07       Impact factor: 2.311

2.  Decrease in cranial nerve complications after radiosurgery for acoustic neuromas: a prospective study of dose and volume.

Authors:  R C Miller; R L Foote; R J Coffey; D J Sargent; D A Gorman; P J Schomberg; R W Kline
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-01-15       Impact factor: 7.038

3.  The natural history of vestibular schwannoma.

Authors:  Sven-Eric Stangerup; Per Caye-Thomasen; Mirko Tos; Jens Thomsen
Journal:  Otol Neurotol       Date:  2006-06       Impact factor: 2.311

4.  Long-term outcomes in patients with vestibular schwannomas treated using gamma knife surgery: 10-year follow up.

Authors:  Toshinori Hasegawa; Yoshihisa Kida; Tatsuya Kobayashi; Masayuki Yoshimoto; Yoshimasa Mori; Jun Yoshida
Journal:  J Neurosurg       Date:  2005-01       Impact factor: 5.115

Review 5.  Complications of the gamma knife.

Authors:  R J Wiet; A G Micco; G P Bauer
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1996-04

6.  Malignant transformation of a vestibular schwannoma after gamma knife radiosurgery.

Authors:  Vijay Yanamadala; Richard W Williamson; David J Fusco; Jennifer Eschbacher; Peter Weisskopf; Randall W Porter
Journal:  World Neurosurg       Date:  2012-04-02       Impact factor: 2.104

7.  Surgical salvage after failed irradiation for vestibular schwannoma.

Authors:  Rick A Friedman; Derald E Brackmann; William E Hitselberger; Marc S Schwartz; Zarina Iqbal; Karen I Berliner
Journal:  Laryngoscope       Date:  2005-10       Impact factor: 3.325

8.  Stereotactic radiotherapy for vestibular schwannomas: favorable outcome with minimal toxicity.

Authors:  Annie W Chan; Peter Black; Robert G Ojemann; Fred G Barker; Hanne M Kooy; Vrishali V Lopes; Michael J McKenna; Dennis C Shrieve; Robert L Martuza; Jay S Loeffler
Journal:  Neurosurgery       Date:  2005-07       Impact factor: 4.654

9.  Radiosurgery for acoustic neuromas: results of low-dose treatment.

Authors:  Yoshiyasu Iwai; Kazuhiro Yamanaka; Masato Shiotani; Taichi Uyama
Journal:  Neurosurgery       Date:  2003-08       Impact factor: 4.654

Review 10.  Hearing preservation after stereotactic radiosurgery for vestibular schwannoma: a systematic review.

Authors:  Isaac Yang; Derrick Aranda; Seunggu J Han; Sravana Chennupati; Michael E Sughrue; Steven W Cheung; Lawrence H Pitts; Andrew T Parsa
Journal:  J Clin Neurosci       Date:  2009-03-20       Impact factor: 1.961

View more
  2 in total

Review 1.  Microsurgical resection of vestibular schwannomas: complication avoidance.

Authors:  Shervin Rahimpour; Allan H Friedman; Takanori Fukushima; Ali R Zomorodi
Journal:  J Neurooncol       Date:  2016-09-20       Impact factor: 4.130

2.  Surgical management for large vestibular schwannomas: a systematic review, meta-analysis, and consensus statement on behalf of the EANS skull base section.

Authors:  Daniele Starnoni; Lorenzo Giammattei; Giulia Cossu; Michael J Link; Pierre-Hugues Roche; Ari G Chacko; Kenji Ohata; Majid Samii; Ashish Suri; Michael Bruneau; Jan F Cornelius; Luigi Cavallo; Torstein R Meling; Sebastien Froelich; Marcos Tatagiba; Albert Sufianov; Dimitrios Paraskevopoulos; Idoya Zazpe; Moncef Berhouma; Emmanuel Jouanneau; Jeroen B Verheul; Constantin Tuleasca; Mercy George; Marc Levivier; Mahmoud Messerer; Roy Thomas Daniel
Journal:  Acta Neurochir (Wien)       Date:  2020-07-29       Impact factor: 2.216

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.